Skip to content
Abierto
Menu

Combined synopsis and solicitation

Atropine & Pralidoxime Chloride Injector, Single Dose Auto- Injectors

75A50324R00005

Office of Assistant Secretary for Preparedness and Response, Aspr/Orm-Sns. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Meridian Medical Technologies, LLC

$82,223,186.40 obligated so far on USAspending

Description

As published on SAM.gov.

The Strategic National Stockpile (SNS), of the U.S. Department of Health and Human Services (HHS) Office of the Administration for Strategic Preparedness and Response (ASPR), has a requirement for Atropine & Pralidoxime Chloride Injector, Single Dose Auto-Injectors. Refer to attached request for proposal (RFP).

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Meridian Medical Technologies, LLC
UEI
VBM4PLZ9VBC4
CAGE
54452
Vendor location
Saint Louis, MO
Contract
75A50324C00015, definitive contract
Obligated
$82,223,186.40, potential $129,680,170
Actions
3 between September 27, 2024 and September 18, 2025
Competition
Full and Open Competition, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Atropine & Pralidoxime Chloride Injector, Single Dose Auto-Injectors
Match
solicitation number 75A50324R00005 equals the FPDS solicitation identifier; same awarding office 75A503 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 7, 2024

    Combined synopsis and solicitation

    Due August 22, 2024 at 4:00 PM EDT. SAM.gov, notice 30ab6f2e83cb477e8b42873b57c02b6b

Points of contact

Also open from this buyer